Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant intra-articular injections for painful knee osteoarthritis
2006-005946-35Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Icatibant with Placebo (2 arms). Primary endpoint: Primary pain endpoint. Started Apr 2007; status: completed.
02
Drugs
icatibant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-005946-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005946-35.